Allocation of Opportunities to Participate in Clinical Trials during the Covid-19 Pandemic and Other Public Health Emergencies
The COVID-19 pandemic exposed that some hospitals lack clinical trial opportunities for patients during public health emergencies. In a new paper in Hastings Center Report,...
Alon Bergman
Alon Bergman, PhD, is an Assistant Professor of Medical Ethics and Health Policy. He also has a secondary appointment as Assistant Professor of Health Care Management in the...
ALS patient who died should force Biogen, others to anticipate expanded access issues
From STAT: A patient with ALS named Lisa Stockman Mauriello who recently battled Biogen for access to a clinical trial passed away recently, raising the issue of expanded...
Alumni Colloquium Series 2024-25
MBE/MSME Alumni Colloquium 2024-25
Alyssa J. Moran
Alyssa J. Moran, ScD, MPH is Director of Policy and Research Strategy at the PEACH Lab. Alyssa has extensive experience working with policymakers, government agencies,...
Alzheimer's patients are desperate for treatment. But the FDA can't throw out its standards.
From Yahoo, written by Holly Fernandez Lynch, Emily A. Largent, and Andrew Peterson: Like many government agencies, the Food and Drug Administration is at its best when no...
Alzheimer’s Tests Soon May Be Common. Should You Get One?
Dr. Jason Karlawish, an Alzheimer’s researcher at the University of Pennsylvania, did a formal study to gauge patients’ responses to learning that they had elevated levels of...